List_of_vaccine_topics

List of vaccine topics

List of vaccine topics

Add article description

This is a list of vaccine-related topics.

Flu vaccines used during the flu in 2009

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe or its toxins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.[1]

Human vaccines

Viral diseases

More information Vaccine(s), Virus ...


Bacterial diseases

More information Vaccine(s), Bacterium ...

Parasitic diseases

More information Vaccine(s), Parasite ...

Vaccines under research

Viral diseases

Bacterial diseases

Parasitic diseases

Non-infectious diseases

Other

Vaccine components

Vaccine trials

Vaccination strategies

Vaccine safety

People

Developers of vaccines

Organizations, conferences and publications

Manufacturers
Other
Advocacy of anti-vaccination opinions

Films supporting vaccination

Other

See also

References

  1. [1]
    Loehr, Jamie (2009). "Vaccine Basics". The Vaccine Answer Book. Naperville, IL: Sourcebooks Inc. ISBN 978-1402223785.
  2. [2]
    Enria, D. A.; Ambrosio, A. M.; Briggiler, A. M.; Feuillade, M. R.; Crivelli, E.; Study Group on Argentine Hemorrhagic Fever Vaccine (2010). "Candid#1 vaccine against Argentine hemorrhagic fever produced in Argentina. Immunogenicity and safety". Medicina. 70 (3): 215–222. PMID 20529769.
  3. [3]
    Negrón, María E.; Kharod, Grishma A.; Bower, William A.; Walke, Henry (2019). "Notes from the Field: Human Brucella abortus RB51 Infections Caused by Consumption of Unpasteurized Domestic Dairy Products – United States, 2017–2019". MMWR. Morbidity and Mortality Weekly Report. 68 (7): 185. doi:10.15585/mmwr.mm6807a6. PMC 6385706. PMID 30789879.
  4. [4]
    Kuschner, R. A.; Russell, K. L.; Abuja, M.; Bauer, K. M.; Faix, D. J.; Hait, H.; Henrick, J.; Jacobs, M.; Liss, A.; Lynch, J. A.; Liu, Q.; Lyons, A. G.; Malik, M.; Moon, J. E.; Stubbs, J.; Sun, W.; Tang, D.; Towle, A. C.; Walsh, D. S.; Wilkerson, D.; Adenovirus Vaccine Efficacy Trial Consortium (2013). "A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. Military recruits". Vaccine. 31 (28): 2963–2971. doi:10.1016/j.vaccine.2013.04.035. PMID 23623865.
  5. [5]
    Kim, D. S.; Nam, J. H. (2010). "Characterization of attenuated coxsackievirus B3 strains and prospects of their application as live-attenuated vaccines". Expert Opinion on Biological Therapy. 10 (2): 179–190. doi:10.1517/14712590903379502. PMID 20088713. S2CID 2700243.
  6. [6]
    Schleiss, M. R. (2008). "Cytomegalovirus Vaccine Development". Human Cytomegalovirus. Current Topics in Microbiology and Immunology. Vol. 325. pp. 361–382. doi:10.1007/978-3-540-77349-8_20. ISBN 978-3-540-77348-1. PMC 2831992. PMID 18637516.
  7. [7]
    Docksai, Rick (May 31, 2017). "DoD Vaccine Research Saves Military, Civilian Lives". US Department of Defense. Retrieved July 7, 2018.
  8. [8]
    Pandya, J.; Gorchakov, R.; Wang, E.; Leal, G.; Weaver, S. C. (2012). "A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation". Vaccine. 30 (7): 1276–1282. doi:10.1016/j.vaccine.2011.12.121. PMC 3283035. PMID 22222869.
  9. [9]
    Zhu, F. C.; Liang, Z. L.; Li, X. L.; Ge, H. M.; Meng, F. Y.; Mao, Q. Y.; Zhang, Y. T.; Hu, Y. M.; Zhang, Z. Y.; Li, J. X.; Gao, F.; Chen, Q. H.; Zhu, Q. Y.; Chu, K.; Wu, X.; Yao, X.; Guo, H. J.; Chen, X. Q.; Liu, P.; Dong, Y. Y.; Li, F. X.; Shen, X. L.; Wang, J. Z. (2013). "Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: A randomised, double-blind, placebo-controlled phase 2 clinical trial". The Lancet. 381 (9871): 1037–1045. doi:10.1016/S0140-6736(12)61764-4. PMID 23352749. S2CID 27961719.
  10. [10]
    Pullen, L.C. (November 7, 2011). "Epstein-Barr Virus Vaccine May Soon Enter Phase 3 Trial". Medscape Today. Retrieved April 24, 2013.
  11. [11]
    "H5N1 Influenza Virus Vaccine, manufactured by Sanofi Pasteur, Inc. Questions and Answers". FDA. April 12, 2019.
  12. [12]
    "Hepatitis C vaccine by Inovio could be tested in humans by end of year". Philadelphia Business Journal. January 9, 2013. Retrieved April 24, 2013.
  13. [13]
    "Researchers a step closer to making HIV vaccine". Medical News Today. April 5, 2013. Retrieved April 24, 2013.
  14. [14]
    Hanabuchi, S.; Ohashi, T.; Koya, Y.; Kato, H.; Hasegawa, A.; Takemura, F.; Masuda, T.; Kannagi, M. (2001). "Regression of human T-cell leukemia virus type I (HTLV-I)-associated lymphomas in a rat model: Peptide-induced T-cell immunity". Journal of the National Cancer Institute. 93 (23): 1775–1783. doi:10.1093/jnci/93.23.1775. PMID 11734593.
  15. [15]
    De Thé, G.; Bomford, R.; Kazanji, M.; Ibrahim, F. (1994). "Human T cell lymphotropic virus: Necessity for and feasibility of a vaccine". Ciba Foundation Symposium. Novartis Foundation Symposia. 187: 47–55, discussion 55–60. doi:10.1002/9780470514672.ch4. ISBN 9780470514672. PMID 7796676.
  16. [16]
    Hampton, T. (2006). "Marburg Vaccine Shows Promise: Offers Postexposure Protection in Monkeys". JAMA. 295 (20): 2346. doi:10.1001/jama.295.20.2346. PMID 16720816.
  17. [17]
    "MERS vaccine shows promise in clinical trial, say researchers".
  18. [18]
    "Developing a vaccine against Nipah virus". ScienceDaily (Press release). April 15, 2019.
  19. [19]
    Keshwara, Rohan; Shiels, Thomas; Postnikova, Elena; Kurup, Drishya; Wirblich, Christoph; Johnson, Reed F.; Schnell, Matthias J. (2019). "Rabies-based vaccine induces potent immune responses against Nipah virus". npj Vaccines. 4: 15. doi:10.1038/s41541-019-0109-5. PMC 6465360. PMID 31016033.
  20. [20]
    Sifferlin, A. (March 22, 2013). "Norovirus leading cause of intestinal disorders in kids". CNN. Retrieved April 24, 2013.
  21. [21]
    Lindell, D. M.; Morris, S. B.; White, M. P.; Kallal, L. E.; Lundy, P. K.; Hamouda, T.; Baker, J. R.; Lukacs, N. W. (2011). Semple, Malcolm Gracie (ed.). "A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease". PLOS ONE. 6 (7): e21823. Bibcode:2011PLoSO...621823L. doi:10.1371/journal.pone.0021823. PMC 3137595. PMID 21789184.
  22. [22]
    Jiang, S.; Lu, L.; Du, L. (2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology. 8 (1): 1–2. doi:10.2217/fvl.12.126. PMC 7079997. PMID 32201503.
  23. [23]
    Hall, R. A.; Khromykh, A. A. (2004). "West Nile virus vaccines". Expert Opinion on Biological Therapy. 4 (8): 1295–1305. doi:10.1517/14712598.4.8.1295. PMID 15268663. S2CID 34176756.
  24. [24]
    Sifferlin, Alexandra (January 21, 2016). "U.S. Launches 'Full-court Press' for a Zika Vaccine". Time. Retrieved January 23, 2016.
  25. [25]
    Shivakumar, K. M.; Vidya, S. K.; Chandu, G. N. (2009). "Dental caries vaccine". Indian Journal of Dental Research. 20 (1): 99–106. doi:10.4103/0970-9290.49066. PMID 19336869.
  26. [26]
    "Collaboration to develop the world's first prophylactic gonorrhoea vaccine". europeanpharmaceuticalreview.com. August 25, 2020. Retrieved May 5, 2023.
  27. [27]
    Rudoler, N.; Baneth, G.; Eyal, O.; Van Straten, M.; Harrus, S. (2012). "Evaluation of an attenuated strain of Ehrlichia canis as a vaccine for canine monocytic ehrlichiosis". Vaccine. 31 (1): 226–233. doi:10.1016/j.vaccine.2012.10.003. PMID 23072894.
  28. [28]
    Svennerholm, AM; Lundgren, A (July 2007). "Progress in vaccine development against Helicobacter pylori". FEMS Immunology and Medical Microbiology. 50 (2): 146–56. doi:10.1111/j.1574-695X.2007.00237.x. PMID 17442014.
  29. [29]
    Walduck, AK; Raghavan, S (2019). Immunity and Vaccine Development Against Helicobacter pylori. Advances in Experimental Medicine and Biology. Vol. 1149. pp. 257–275. doi:10.1007/5584_2019_370. ISBN 978-3-030-21915-4. PMID 31016627. S2CID 129943113.
  30. [30]
    McGuinness, R. (November 20, 2012). "Search for leprosy vaccine continues as disease still affects thousands". Metro News. Retrieved May 29, 2013.
  31. [31]
    "Lyme Disease Vaccine". Lyme Info. Retrieved April 24, 2013.
  32. [32]
    Bagnoli, F.; Bertholet, S.; Grandi, G. (2012). "Inferring Reasons for the Failure of Staphylococcus aureus Vaccines in Clinical Trials". Frontiers in Cellular and Infection Microbiology. 2: 16. doi:10.3389/fcimb.2012.00016. PMC 3417391. PMID 22919608.
  33. [33]
    Guilherme, L.; Ferreira, F. M.; Köhler, K. F.; Postol, E.; Kalil, J. (2013). "A Vaccine against Streptococcus pyogenes". American Journal of Cardiovascular Drugs. 13 (1): 1–4. doi:10.1007/s40256-013-0005-8. PMID 23355360. S2CID 13071864.
  34. [34]
    Cullen, P. A.; Cameron, C. E. (2006). "Progress towards an effective syphilis vaccine: The past, present and future". Expert Review of Vaccines. 5 (1): 67–80. doi:10.1586/14760584.5.1.67. PMID 16451109. S2CID 31534855.
  35. [35]
    Conlan, J. W. (2011). "Tularemia vaccines: Recent developments and remaining hurdles". Future Microbiology. 6 (4): 391–405. doi:10.2217/fmb.11.22. PMID 21526941.
  36. [36]
    Titball, R. W.; Williamson, E. D. (2004). "Yersinia pestis (plague) vaccines". Expert Opinion on Biological Therapy. 4 (6): 965–973. doi:10.1517/14712598.4.6.965. PMID 15174978. S2CID 43565534.
  37. [37]
    "Potential Chagas Vaccine Candidate Shows Unprecedented Efficacy". ScienceDaily (Press release). March 26, 2013. Retrieved September 14, 2013.
  38. [38]
    Gupta, Shivali; Garg, Nisha Jain (2013). "TcVac3 Induced Control of Trypanosoma cruzi Infection and Chronic Myocarditis in Mice". PLOS ONE. 8 (3): e59434. Bibcode:2013PLoSO...859434G. doi:10.1371/journal.pone.0059434. PMC 3608676. PMID 23555672.
  39. [39]
    Rattue, Grace (January 20, 2012). "Human hookworm vaccine trial". Medical News Today. Retrieved April 24, 2013.
  40. [40]
    Nakkazi, E. (March 12, 2012). "New vaccine trials to prevent visceral leishmaniasis". New Science Journalism. Retrieved June 16, 2013.
  41. [41]
    Vogel, G. (March 20, 2013). "More Sobering Results for Malaria Vaccine". Science Magazine. Archived from the original on May 10, 2013. Retrieved April 24, 2013.
  42. [42]
    Sanjit Bagchi (April 26, 2006). "Study raises hopes of vaccine for river blindness". SciDev Net. Retrieved April 24, 2013.
  43. [43]
    Siddiqui, A. A.; Siddiqui, B. A.; Ganley-Leal, L. (2011). "Schistosomiasis vaccines". Human Vaccines. 7 (11): 1192–1197. doi:10.4161/hv.7.11.17017. PMC 3323497. PMID 22048120.
  44. [44]
    La Greca, F.; Magez, S. (2011). "Vaccination against trypanosomiasis: Can it be done or is the trypanosome truly the ultimate immune destroyer and escape artist?". Human Vaccines. 7 (11): 1225–1233. doi:10.4161/hv.7.11.18203. PMC 3323498. PMID 22205439.
  45. [45]
    Keller, D. M. (April 22, 2013). "Alzheimer's Vaccine Shows Efficacy Without Adverse Effects". Medscape News. Retrieved May 29, 2013.
  46. [46]
    McFadden, M. (October 11, 2012). "Revolutionary breast cancer vaccine 100% effective in mice: awaits human trials". WNDU. Archived from the original on June 27, 2017. Retrieved May 12, 2013.
  47. [47]
    "Ovarian cancer vaccine shows promise in trial". Fox News. April 8, 2013. Retrieved April 24, 2013.
  48. [48]
    Jonhson, K. (March 21, 2013). "Prostate Cancer Vaccine Shows Promise". Medscape Today. Retrieved April 24, 2013.
  49. [49]
    Ball, Philip (August 26, 2017). "Could a heroin vaccine cure the west's drug epidemic?". The Guardian. Retrieved March 6, 2022.
Share this article:

This article uses material from the Wikipedia article List_of_vaccine_topics, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.